Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 264 IDR -2.22% Market Closed
Market Cap: 3T IDR
Have any thoughts about
Pyridam Farma Tbk PT?
Write Note

Intrinsic Value

The intrinsic value of one PYFA stock under the Base Case scenario is 113.82 IDR. Compared to the current market price of 264 IDR, Pyridam Farma Tbk PT is Overvalued by 57%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PYFA Intrinsic Value
113.82 IDR
Overvaluation 57%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Pyridam Farma Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PYFA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PYFA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Pyridam Farma Tbk PT

Provide an overview of the primary business activities
of Pyridam Farma Tbk PT.

What unique competitive advantages
does Pyridam Farma Tbk PT hold over its rivals?

What risks and challenges
does Pyridam Farma Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pyridam Farma Tbk PT.

Provide P/S
for Pyridam Farma Tbk PT.

Provide P/E
for Pyridam Farma Tbk PT.

Provide P/OCF
for Pyridam Farma Tbk PT.

Provide P/FCFE
for Pyridam Farma Tbk PT.

Provide P/B
for Pyridam Farma Tbk PT.

Provide EV/S
for Pyridam Farma Tbk PT.

Provide EV/GP
for Pyridam Farma Tbk PT.

Provide EV/EBITDA
for Pyridam Farma Tbk PT.

Provide EV/EBIT
for Pyridam Farma Tbk PT.

Provide EV/OCF
for Pyridam Farma Tbk PT.

Provide EV/FCFF
for Pyridam Farma Tbk PT.

Provide EV/IC
for Pyridam Farma Tbk PT.

Compare the intrinsic valuations
of Pyridam Farma Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pyridam Farma Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pyridam Farma Tbk PT compared to its peers.

Compare the P/E ratios
of Pyridam Farma Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Pyridam Farma Tbk PT with its peers.

Analyze the financial leverage
of Pyridam Farma Tbk PT compared to its main competitors.

Show all profitability ratios
for Pyridam Farma Tbk PT.

Provide ROE
for Pyridam Farma Tbk PT.

Provide ROA
for Pyridam Farma Tbk PT.

Provide ROIC
for Pyridam Farma Tbk PT.

Provide ROCE
for Pyridam Farma Tbk PT.

Provide Gross Margin
for Pyridam Farma Tbk PT.

Provide Operating Margin
for Pyridam Farma Tbk PT.

Provide Net Margin
for Pyridam Farma Tbk PT.

Provide FCF Margin
for Pyridam Farma Tbk PT.

Show all solvency ratios
for Pyridam Farma Tbk PT.

Provide D/E Ratio
for Pyridam Farma Tbk PT.

Provide D/A Ratio
for Pyridam Farma Tbk PT.

Provide Interest Coverage Ratio
for Pyridam Farma Tbk PT.

Provide Altman Z-Score Ratio
for Pyridam Farma Tbk PT.

Provide Quick Ratio
for Pyridam Farma Tbk PT.

Provide Current Ratio
for Pyridam Farma Tbk PT.

Provide Cash Ratio
for Pyridam Farma Tbk PT.

What is the historical Revenue growth
over the last 5 years for Pyridam Farma Tbk PT?

What is the historical Net Income growth
over the last 5 years for Pyridam Farma Tbk PT?

What is the current Free Cash Flow
of Pyridam Farma Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pyridam Farma Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pyridam Farma Tbk PT

Current Assets 1.7T
Cash & Short-Term Investments 505.4B
Receivables 617.5B
Other Current Assets 589.9B
Non-Current Assets 4.2T
Long-Term Investments 99.7B
PP&E 1.5T
Intangibles 2.5T
Other Non-Current Assets 21.1B
Current Liabilities 2.3T
Accounts Payable 303.6B
Accrued Liabilities 98.5B
Short-Term Debt 1.7T
Other Current Liabilities 184.3B
Non-Current Liabilities 2.4T
Long-Term Debt 2.1T
Other Non-Current Liabilities 291.3B
Efficiency

Earnings Waterfall
Pyridam Farma Tbk PT

Revenue
1.3T IDR
Cost of Revenue
-975.6B IDR
Gross Profit
367.9B IDR
Operating Expenses
-495.7B IDR
Operating Income
-127.8B IDR
Other Expenses
-126.2B IDR
Net Income
-254B IDR

Free Cash Flow Analysis
Pyridam Farma Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PYFA Profitability Score
Profitability Due Diligence

Pyridam Farma Tbk PT's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive 3-Year Average ROE
47/100
Profitability
Score

Pyridam Farma Tbk PT's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

PYFA Solvency Score
Solvency Due Diligence

Pyridam Farma Tbk PT's solvency score is 19/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
High D/E
Positive Net Debt
19/100
Solvency
Score

Pyridam Farma Tbk PT's solvency score is 19/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PYFA Price Targets Summary
Pyridam Farma Tbk PT

There are no price targets for PYFA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PYFA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PYFA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT

Country

Indonesia

Industry

Pharmaceuticals

Market Cap

3T IDR

Dividend Yield

0%

Description

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

Contact

DKI JAKARTA
Jakarta
Sinarmas MSIG Tower, 12th floor, Jl. Jend. Sudirman no.kav. 21, RT.10/RE.01, Kuningan, Karet, Kecamatan Setiabudi
+622153690112
www.pyfa.co.id

IPO

2001-10-16

Employees

1 539

Officers

President Director
Mr. Yan Gwan Lee
CFO & Director
Mr. Yenfrino Gunadi
COO, Head of Pharmacovigilance & Director
Dr. Paulus Widjanarko Brotosaputro
Finance, Accounting & Tax Manager
Sinta Lestari Ningsih
Head of Legal & Corporate Secretary
Ms. Nadia Miranty Verdiana
HRD Manager
Joshua Sandjaja
Show More
Head of OTC
Andrey Septiana
Head of Internal Audit Unit
Ms. - Yoshiana
Show Less

See Also

Discover More
What is the Intrinsic Value of one PYFA stock?

The intrinsic value of one PYFA stock under the Base Case scenario is 113.82 IDR.

Is PYFA stock undervalued or overvalued?

Compared to the current market price of 264 IDR, Pyridam Farma Tbk PT is Overvalued by 57%.

Back to Top